Guru Ownership Trend
Guru Analysis for Sutro Biopharma, Inc. (STRO)
Sutro Biopharma, Inc. (STRO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $24.37 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $11.92 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 286.5%. Conversely, Cliff Asness reduced exposure by 52.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Sutro Biopharma, Inc. (STRO)
Major holders include Steven Cohen ($17.24 M), Renaissance Technologies (RenTech) ($2.44 M), Ken Fisher ($879,198). According to the latest reported data, 4 tracked investment managers collectively hold approximately 833,835 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $11.92 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited STRO. The total reported sell value was $858,897.33.
Yes, 0 managers opened new positions in STRO, and 1 increased their existing holdings. The total reported buy value was $12.78 M.